Hereditary ovarian cancer

QR Code

Hereditary ovarian cancer

Background. Hereditary genetic mutations are a significant risk factor for malignant transformation of cells and cancer development. Hereditary genetic mutations account for 15 to 25 % of all ovarian carcinomas. Purpose of the study: to summarize data on hereditary ovarian malignancies, namely: gene...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kh. B. Kotiv, T. V. Gorodnova, A. P. Sokolenko, I. V. Berlev, E. N. Imyanitov
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2022-11-01
Series:	Сибирский онкологический журнал
Subjects:	hereditary ovarian cancer brca mutations lynch syndrome mutations in the genes msh2 mlh1 msh6 pms2 epcam brip1 rad51c rad51d atm nbn stk11 palb2
Online Access:	https://www.siboncoj.ru/jour/article/view/2315
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

IMMUNOHISTOCHEMICAL STUDY OF MSH2, MSH6, PMS2, MLH1 IN EVALUATION OF DIFFERENTIATION GRADE OF COLON ADENOCARCINOMA
by: G. A. Raskin, et al.
Published: (2016-02-01)

Main risk factors for breast cancer and proposals for its prevention
by: S. M. Portnoy
Published: (2018-10-01)

The Anticancer Effect of RAD51-IN-1 in MDAH-2774 (CVCL_0420) Cells
by: Deniz ÖZDEMİR, et al.
Published: (2025-04-01)

CLINICAL AND MORPHOLOGICAL FEATURES OF HEREDITARY OVARIAN CANCER
by: K. B. Kotiv, et al.
Published: (2017-12-01)

Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy
by: Apar Pataer, et al.
Published: (2018-06-01)

Identification of the Oncogenic Role of MSH2 in the Stemness and Progression of Glioma Through Regulating Wnt Signaling Pathway
by: Jun Liu, et al.
Published: (2025-07-01)

BRCA1, BRCA2 mutations — future of predictive oncology: a review of literature
by: V. N. Dmitriev, et al.
Published: (2014-07-01)

DETECTION OF MUTATIONS RELATED TO HEREDITARY CANCER IN RELATIVES OF BREAST CANCER PATIENTS
by: G. A. Paul, et al.
Published: (2017-09-01)

REPARATION SYSTEM GENES: POPULATION DIFFERENCES IN HEREDITARY OVARIAN AND BREAST CANCER DETERMINED BY NEXT-GENERATION SEQUENCING
by: O. I. Brovkina, et al.
Published: (2017-06-01)

A RARE CASE OF MULTIPLE-PRIMARY CANCER IN A WOMAN WITH BRCA 1 GENE MUTATION: BRCA-ASSOCIATED OVARIAN CANCER AND LUNG CARCINOID TUMOR
by: A. О. Ivantsov, et al.
Published: (2018-03-01)

Modulation of TvRAD51 Recombinase in <i>Trichomonas vaginalis</i> by Zinc and Cadmium as a Potential Mechanism for Genotoxic Stress Response
by: Jonathan Puente-Rivera, et al.
Published: (2025-06-01)

High rate of mutations in the BRCA1, BRCA2, CHEK2, NBN, and BLM genes in Russian ovarian cancer patients
by: Ye. I. Bateneva, et al.
Published: (2015-01-01)

Case Report: Clinical impact of BRCA1 and BRIP1 vs. BRCA1 and BRCA2 germline double heterozygosity in ovarian cancer: a comparative case study
by: Limei Zheng, et al.
Published: (2025-07-01)

Features and complexity of treatment of <i>BRCA</i>-associated ovarian cancer, chronic disease: literature review
by: T. V. Gorodnova, et al.
Published: (2024-11-01)

Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
by: S. V. Boichuk, et al.
Published: (2015-06-01)

Enhanced sensitivity, robust p21 activation, and sustained DNA repair responses to interstrand crosslinks in elephant cells compared to humans
by: Taisuke Kitano, et al.
Published: (2025-07-01)

Prophylactic adnexectomy in BRCA1 and BRCA2 gene mutation carriers (а review of literature)
by: T. A. Shendrikova, et al.
Published: (2014-07-01)

Ethnic aspects of hereditary breast cancer
by: P. A. Gervas, et al.
Published: (2019-04-01)

STK11 mutation impacts CD1E expression to regulate the differentiation of macrophages in lung adenocarcinoma
by: Qingfeng Zhang, et al.
Published: (2023-07-01)

Role of BRCA 1 и BRCA 2 gene mutations in the occurrence of male breast cancer
by: A. V. Bykova, et al.
Published: (2014-07-01)

Hereditary breast cancer: genetic and clinical hetergeneity, genetic testing, prophylactic surgery
by: L. N. Lyubchenko, et al.
Published: (2015-06-01)

The DNA mismatch repair protein, MSH6 is a novel regulator of PD-L1 expression
by: Kirsten Brooksbank, et al.
Published: (2025-09-01)

The efficacy of olaparib as salvage therapy in an advanced intrahepatic cholangiocarcinoma patient harboring somatic BRCA1 and PALB2 pathogenic variants: a case report and literature review
by: Jian Wang, et al.
Published: (2025-08-01)

HRD-negative high-grade carcinoma of the ovary in <i>BRCA2</i> pathogenic variant carrier
by: A. P. Sokolenko, et al.
Published: (2024-05-01)

A systematic review on the association between ovarian and prostate cancer with <I>BRCA1</I> and <I>BRCA2</I> gene
by: Sarpparajan Chitra Veena, et al.
Published: (2023-01-01)

Role of detection of mutations in the <i>BRСA1,2</i>, <i>CHEK2</i>, <i>PALB2</i> genes in diagnosis of oncological diseases and determination of the therapy strategy
by: A. N. Toropovskii, et al.
Published: (2023-03-01)

Diagnosis and treatment of ovarian cancer in the light of modern molecular genetic achievements
by: E. M. Kagirova, et al.
Published: (2023-11-01)

Results of a preliminary analysis of the pattern of hereditary breast cancer in the women of a Kyrgyz population
by: K. B. Makieva, et al.
Published: (2014-07-01)

Genotype-phenotype correlations in patients with breast cancer and BRCA1 mutations (4153delA, 185delAG, 5382insC)
by: Ye. M. Bit-Sava, et al.
Published: (2014-07-01)

MEDICAL AND GENETIC COUNSELING OF HEREDITARY BREAST AND OVARIAN CANCER
by: S. A. Laptiev, et al.
Published: (2018-06-01)

HEREDITARY CHARACTERISTICS BRCA1 5382INSC/СHEK2/BLM-ASSOCIATED BREAST CANCER
by: Е. М. Bit-Sava
Published: (2016-02-01)

Prognostic Value of BRCA1 and BRCA2 Gene Mutations in Prostate Cancer: a Literature Review
by: M. V. Loginova, et al.
Published: (2021-05-01)

Breast cancer screening in germline mutation carriers. A literature review
by: A. V. Sultanbaev, et al.
Published: (2023-08-01)

Genetic Predictors of Malignancy: a Literature Review
by: A. V. Pushkarev, et al.
Published: (2021-05-01)

LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER
by: M. M. Tsyganov, et al.
Published: (2020-07-01)

Role of Genetic Testing and Complex Endoscopic Examination in Differential Diagnosis of Hereditary Polyposes in Pediatric and Adolescent Patients: 10 Years Clinical Experience
by: Tatiana S. Belysheva, et al.
Published: (2023-08-01)

Generating a database by calculating the pathogenic variants and allele frequencies detected in hereditary cancers using genomic data: A nation study
by: Manal Salah Babiker Ali, et al.
Published: (2025-09-01)

Breast cancer risk factors assessment and BRCA-associated breast cancer evaluation in mammographic screening in India
by: S. K. Ternovoy, et al.
Published: (2014-07-01)

HEREDITARY MULTIPLE PRIMARY BREAST AND OVARIAN CANCER (CASE REPORT)
by: Е. V. Panferova, et al.
Published: (2016-02-01)

Hereditary breast cancer and ovarian cancer: clinical course and treatment
by: V. V. Semiglazov, et al.
Published: (2021-03-01)